Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
65.8 USD | +0.39% | +1.03% | -18.68% |
May. 02 | UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating | MT |
May. 01 | Deutsche Bank Adjusts Price Target on Gilead Sciences to $73 From $75 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.68% | 81.73B | |
+32.88% | 690B | |
+26.43% | 546B | |
-4.87% | 358B | |
+18.16% | 323B | |
+4.99% | 287B | |
+14.32% | 235B | |
+5.79% | 199B | |
-9.49% | 195B | |
+4.96% | 161B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- TD Cowen Adjusts Price Target on Gilead Sciences to $85 From $90